Skip to search boxSkip to navigationSkip to main content

O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension

  • Victor V. Lima
    ,
  • Christiné S. Rigsby
    ,
  • David M. Hardy
    ,
  • R. Clinton Webb
    ,
  • Rita C. Tostes(corresponding author)
*Corresponding author for this work
  • Universidade de São Paulo
    ,
  • Medical College of Georgia
    ,
Scholary Output:
Contribution to journal
Review article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

O-Linked attachment of β-N-acetyl-glucosamine (O-GlcNAc) on serine and threonine residues of nuclear and cytoplasmic proteins is a highly dynamic posttranslational modification that plays a key role in signal transduction pathways. Preliminary data show that O-GlcNAcylation may represent a key regulatory mechanism in the vasculature, modulating contractile and relaxant responses. Proteins with an important role in vascular function, such as endothelial nitric oxide synthase, sarcoplasmic reticulum Ca2+-ATPase, protein kinase C, mitogen-activated protein kinases, and proteins involved in cytoskeleton regulation and microtubule assembly are targets for O-GlcNAcylation, indicating that this posttranslational modification may play an important role in vascular reactivity. Here, we will focus on a few specific pathways that contribute to vascular function and cardiovascular disease-associated vascular dysfunction, and the implications of their modification by O-GlcNAc. New chemical tools have been developed to detect and study O-GlcNAcylation, including inhibitors of O-GlcNAc enzymes, chemoenzymatic tagging methods, and quantitative proteomics strategies; these will also be briefly addressed. An exciting challenge in the future will be to better understand the cellular dynamics of this posttranslational modification, as well as the signaling pathways and mechanisms by which O-GlcNAc is regulated on specific proteins in the vasculature in health and disease.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 374-387 (14 pages)

Journal (Volume, Issue Number)

Journal of the American Society of Hypertension (Volume 3, Issue 6)

Publication milestones

  • Published - 11/2009

Publication status

Published - 11/2009

ISSN

1933-1711

Publication IDs

  • Scopus: 70549093288
  • PubMed: 20409980

Publication metrics

Metrics

SciVal
FWCI
0.63
SciVal
Author count
5
SciVal
citations
28
SciVal
Paper percentile
81
Fractional count
1
Fractional count
0.20
Fractional count
4
Fractional count
0.80
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
42
Citation count
39
Mentions
2

Funding Details

Supported by the National Institutes of Health and Cardiovascular Discovery Institute, EUA and CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), Brazil.
FundersFunding numbers
EUA
-
National Institutes of Health and Cardiovascular Discovery Institute
-
CAPES
-